Sonali Jindal

20PUBLICATIONS
208CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 07, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Mar 10, 2026
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma.

JongHoon Ha, Yifan Wang, Yifan Ma

|Feb 23, 2026
Spatial immune hubs defined by conserved activated dendritic cells are remodeled by immunotherapy.

Tomoyuki Minowa, Sunita Keshari, Shan He

|Jan 09, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

|Aug 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

|Apr 28, 2025
Investigative needle core biopsies support multimodal deep-data generation in glioblastoma.

Kenny K H Yu, Sreyashi Basu, Gerard Baquer

Pageof 4

Frequent Collaborators

15 joint publications

Padmanee Sharma

13 joint publications

Sreyashi Basu

7 joint publications

Sangeeta Goswami

4 joint publications

Pepper Schedin